|
|
Article: Nasal spray form for allergic rhinitis
- Article from:
- Formulary
- Article date:
- November 1, 1999
- Author:
CopyrightCopyright Advanstar Communications, Inc. Nov 1999. Provided by ProQuest LLC. (Hide copyright information)
|
The FDA has approved a nasal spray formulation of budesonide for the management of seasonal and perennial allergic rhinitis in patients aged 6 years or older. This corticosteroid was previously approved for this indication in a metered-dose inhaler formulation.
Approval of the new formulation was based on placebo-controlled trials in 141 subjects aged 6 to 12 years and 1,385 subjects aged 12 or older with seasonal or perennial allergic rhinitis. Overall, budesonide nasal spray brought about a statistically significant reduction in the severity of nasal symptoms such as runny nose, ...